![](/img/cover-not-exists.png)
3069 Impact of alectinib on survival after crizotinib failure in ALK-positive NSCLC patients
Yoshida, T., Oya, Y., Tanaka, K., Junichi, S., Yoshitsugu, H., Hida, T., Yatabe, Y.Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31711-7
Date:
September, 2015
File:
PDF, 59 KB
english, 2015